Intranasal Insulin Improves Memory in Humans: Superiority of Insulin Aspart

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703 · see citing works

The Neurobiology of Consolidations, Or, How Stable is the Engram?

Dudai, Y. (2004) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.142050 · Cited by 1,671 · see citing works

Untitled work

Eichenbaum (2004) · doi:10.1016/j.neuron.2004.08.028 · Cited by 1,464 · see citing works

Sniffing neuropeptides: A transnasal approach to the human brain

Born, J., Lange, T., Kern, W., McGregor, G. P., Bickel, U., & Fehm, H. L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-849 · Cited by 1,356 · see citing works

Structure and function of declarative and nondeclarative memory systems

Squire, L. R., & Zola, S. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13515 · Cited by 1,327 · see citing works

Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity

Liu, L., Wong, T. P., Pozza, M. F., Lingenhoehl, K., Wang, Y., Sheng, M., Auberson, Y. P., & Wang, Y. T. (2004) · Science · doi:10.1126/science.1096615 · Cited by 1,106 · see citing works

Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration

Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958 · see citing works

Transport of drugs from the nasal cavity to the central nervous system

Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907 · see citing works

Insulin and neurodegenerative disease: shared and specific mechanisms

Craft, S., & Stennis Watson, G. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00681-7 · Cited by 830 · see citing works

Interference and forgetting.

Underwood, B. J. (1957) · Psychological Review · doi:10.1037/h0044616 · Cited by 815 · see citing works

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739 · see citing works

Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine

Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · see citing works

Intranasal insulin improves memory in humans

Benedict, C., Hallschmid, M., Hatke, A., Schultes, B., Fehm, H. L., Born, J., & Kern, W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.04.003 · Cited by 699 · see citing works

The assessment of insulin resistance in man

Wallace, T. M., & Matthews, D. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00745.x · Cited by 678 · see citing works

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 621 · see citing works

Memory improvement following induced hyperinsulinemia in Alzheimer’s disease

Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02002-0 · Cited by 538 · see citing works

Brain Insulin Receptors and Spatial Memory

Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M. J., & Alkon, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34893 · Cited by 535 · see citing works

Insulin and the insulin receptor in experimental models of learning and memory

Zhao, W., Chen, H., Quon, M. J., & Alkon, D. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.045 · Cited by 503 · see citing works

Monomeric Insulins and Their Experimental and Clinical Implications

Brange, J., Owens, D. R., Kang, S., & Vølund, A. (1990) · Diabetes Care · doi:10.2337/diacare.13.9.923 · Cited by 369 · see citing works

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes

Hermansen, K., Fontaine, P., Kukolja, K. K., Peterkova, V., Leth, G., & Gall, M.-A. (2004) · Diabetologia · doi:10.1007/s00125-004-1365-z · Cited by 365 · see citing works

Insulin-Like Growth Factor-I Promotes Neurogenesis and Synaptogenesis in the Hippocampal Dentate Gyrus during Postnatal Development

O'Kusky, J. R., Ye, P., & D'Ercole, A. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08435.2000 · Cited by 358 · see citing works

The hippocampus and mechanisms of declarative memory

Eichenbaum, H. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00044-3 · Cited by 353 · see citing works

Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose

Craft, S., Asthana, S., Newcomer, J. W., Wilkinson, C. W., Matos, I. T., Baker, L. D., Cherrier, M., Lofgreen, C., Latendresse, S., Petrova, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1135 · Cited by 312 · see citing works

Improving influence of insulin on cognitive functions in humans

Kern, W., Peters, A., Fruehwald-Schultes, B., Deininger, E., Born, J., & Fehm, H. L. (2001) · Neuroendocrinology · doi:10.1159/000054694 · Cited by 308 · see citing works

Insulin promotes rapid delivery of N -methyl- d - aspartate receptors to the cell surface by exocytosis

Skeberdis, V. A., Lan, J.-Y., Zheng, X., Zukin, R. S., & Bennett, M. V. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051634698 · Cited by 303 · see citing works

Insulin modulates hippocampal activity‐dependent synaptic plasticity in a <i>N</i>‐methyl‐<scp>d</scp>‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner

Van Der Heide, L. P., Kamal, A., Artola, A., Gispen, W. H., & Ramakers, G. M. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03269.x · Cited by 278 · see citing works

Potential roles of insulin and IGF-1 in Alzheimer's disease

Gasparini, L., & Xu, H. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00163-2 · Cited by 275 · see citing works

Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype

Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M. M., Purganan, K., Wait, C., Petrova, A., Latendresse, S. J., Watson, G. S., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00087-2 · Cited by 255 · see citing works

Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

Ross, T. M., Martinez, P. M., Renner, J. C., Thorne, R. G., Hanson, L. R., & Frey, W. H. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.011 · Cited by 242 · see citing works

Varieties of human spatial memory: a meta-analysis on the effects of hippocampal lesions

Kessels, R. P. C., de Haan, E. H. F., Kappelle, L. J., & Postma, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00058-3 · Cited by 224 · see citing works

NMDA Receptors and Learning and Memory Processes

Castellano, C., Cestari, V., & Ciamei, A. (2001) · Current Drug Targets · doi:10.2174/1389450013348515 · Cited by 197 · see citing works

Insulin analogs with improved pharmacokinetic profiles

Brange, J., & Vølund, A. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00079-9 · Cited by 194 · see citing works

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes

Rašlová, K., Bogoev, M. K., Raz, I., Leth, G., Gall, M. ‐., & Hâncu, N. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.03.003 · Cited by 193 · see citing works

Central nervous system effects of intranasally administered insulin during euglycemia in men.

Kern, W., Jan Born, A., Schreiber, H., & Fehm, H. (1999) · Diabetes · doi:10.2337/diabetes.48.3.557 · Cited by 192 · see citing works

The Neuroanatomy of Remote Memory

Bayley, P. J., Gold, J. J., Hopkins, R. O., & Squire, L. R. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.034 · Cited by 178 · see citing works

Tracking Insulin to the Mind

Wickelgren, I. (1998) · Science · doi:10.1126/science.280.5363.517 · Cited by 169 · see citing works

New Twist on Neuronal Insulin Receptor Signaling in Health, Disease, and Therapeutics

Wada, A., Yokoo, H., Yanagita, T., & Kobayashi, H. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.crj05006x · Cited by 95 · see citing works

Comparison of Subcutaneous Soluble Human Insulin and Insulin Analogues (AspB9, GluB27; AspB10; AspB28) on Meal-Related Plasma Glucose Excursions in Type I Diabetic Subjects

Kang, S., CREAGH, F. M., Peters, J. R., Brange, J., Vølund, A., & Owens, D. R. (1991) · Diabetes Care · doi:10.2337/diacare.14.7.571 · Cited by 88 · see citing works

Insulin receptor substrate-1 (IRS-1) expression in rat brain

Baskin, D. G., Schwartz, M. W., Sipols, A. J., D’Alessio, D. A., Goldstein, B. J., & White, M. F. (1994) · Endocrinology · doi:10.1210/endo.134.4.7511094 · Cited by 86 · see citing works

Adaptation of cognitive function to hypoglycemia in healthy men.

Fruehwald‐Schultes, B., Jan Born, A., Kern, W., Peters, A., & Fehm, H. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1059 · Cited by 68 · see citing works

Insulin Affects the Neuronal Response in the Medial Temporal Lobe in Humans

Rotte, M., Baerecke, C., Pottag, G., Klose, S., Kanneberg, E., Heinze, H., & Lehnert, H. (2005) · Neuroendocrinology · doi:10.1159/000084874 · Cited by 48 · see citing works

Insulin aspart: a novel rapid-acting human insulin analogue

Gammeltoft, S., Hansen, B. F., Dideriksen, L., Lindholm, A., Schäffer, L., Trüb, T., Dayan, A. D., & Kurtzhals, P. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.9.1431 · Cited by 43 · see citing works

The temporal course of proactive inhibition for serial lists.

Postman, L. J. (1962) · Journal of Experimental Psychology · doi:10.1037/h0048063 · Cited by 39 · see citing works

Intranasal delivery to the central nervous system: Mechanisms and experimental considerations

Dhuria, S. V., Hanson, L. R., & Frey, W. H. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21924 · Cited by 1,239 · see citing works

Alzheimer’s disease is type 3 diabetes—Evidence reviewed

de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · see citing works

Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches

Kellar, D., & Craft, S. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30231-3 · Cited by 832 · see citing works

Mechanism of intranasal drug delivery directly to the brain

Crowe, T. P., Greenlee, M. H. W., Kanthasamy, A. G., & Hsu, W. H. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.025 · Cited by 721 · see citing works

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 700 · see citing works

Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

De Felice, F. G., Vieira, M. N. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., Viola, K. L., Zhao, W.-Q., Ferreira, S. T., & Klein, W. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809158106 · Cited by 657 · see citing works

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630 · see citing works

Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans

Kullmann, S., Heni, M., Hallschmid, M., Fritsche, A., Preissl, H. T., & Häring, H. (2016) · Physiological Reviews · doi:10.1152/physrev.00032.2015 · Cited by 632 · see citing works

Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice

Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.003 · Cited by 511 · see citing works

Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence

Freiherr, J., Hallschmid, M., Frey, W. H., Brünner, Y. F., Chapman, C. D., Hölscher, C., Craft, S., Felice, F. G. D., & Benedict, C. (2013) · CNS Drugs · doi:10.1007/s40263-013-0076-8 · Cited by 470 · see citing works

Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia

Claxton, A., Baker, L. D., Hanson, A., Trittschuh, E. H., Cholerton, B., Morgan, A., Callaghan, M., Arbuckle, M., Behl, C., & Craft, S. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141791 · Cited by 467 · see citing works

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease

de la Monte, S. M. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 446 · see citing works

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

Kim, B., & Feldman, E. L. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.3 · Cited by 357 · see citing works

Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial

Craft, S., Claxton, A., Baker, L. D., Hanson, A. J., Cholerton, B., Trittschuh, E. H., Dahl, D., Caulder, E., Neth, B., Montine, T. J., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161256 · Cited by 335 · see citing works

Intranasal Treatment of Central Nervous System Dysfunction in Humans

Chapman, C. D., Frey, W. H., Craft, S., Danielyan, L., Hallschmid, M., Schiöth, H. B., & Benedict, C. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0915-1 · Cited by 310 · see citing works

Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives

Béard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.825816 · Cited by 309 · see citing works

Aberrant insulin signaling in Alzheimer's disease: current knowledge

Bedse, G., Domenico, F. D., Serviddio, G., & Cassano, T. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00204 · Cited by 294 · see citing works

Insulin in the Brain: Sources, Localization and Functions

Ghasemi, R., Haeri, A., Dargahi, L., Mohamed, Z., & Ahmadiani, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8339-9 · Cited by 291 · see citing works

The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

Batista, A. F., Forny‐Germano, L., Clarke, J. R., Silva, N. M. L. E., Brito‐Moreira, J., Boehnke, S. E., Winterborn, A., Coe, B. C., Lablans, A., Vital, J. F. S., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5056 · Cited by 246 · see citing works

Impaired insulin action in the human brain: causes and metabolic consequences

Heni, M., Kullmann, S., Preissl, H., Fritsche, A., & Häring, H.-U. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.173 · Cited by 245 · see citing works

Nose-to-Brain Delivery

Wang, Z., Xiong, G., Tsang, W. C., Schätzlein, A. G., & Uchegbu, I. F. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258152 · Cited by 243 · see citing works

Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease

Atamna, H., & Frey, W. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.06.001 · Cited by 278 · see citing works

Brain insulin signaling: A key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes

McNay, E. C., & Recknagel, A. K. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.005 · Cited by 229 · see citing works

Insulin Resistance in Alzheimer's Disease

Ferreira, L. S. S., Fernandes, C., Vieira, M. N. N., & Felice, F. G. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00830 · Cited by 229 · see citing works

Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke

Hanson, L. R., Roeytenberg, A., Martinez, P. M., Coppes, V. G., Sweet, D. C., Rao, R. J., Marti, D. L., Hoekman, J., Matthews, R. B., Frey, W. H., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149807 · Cited by 224 · see citing works

Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment

Анатольевич, П. И., Costa-Nunes, J. P., Kasatkin, V. N., Veniaminova, E. A., Demchenko, A. G., Lyundup, A. V., Lesch, K., Ponomarev, E. D., & Strekalova, T. V. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12866 · Cited by 208 · see citing works

A look inside the diabetic brain: Contributors to diabetes-induced brain aging

Wrighten, S. A., Piroli, G. G., Grillo, C. A., & Reagan, L. P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.013 · Cited by 195 · see citing works

Trigeminal Pathways Deliver a Low Molecular Weight Drug from the Nose to the Brain and Orofacial Structures

Johnson, N. J., Hanson, L. R., & Frey, W. H. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100029t · Cited by 194 · see citing works

From nose to brain: understanding transport capacity and transport rate of drugs

Wu, H., Hu, K., & Jiang, X. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.10.1159 · Cited by 188 · see citing works

Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders

MacDonald, K., & Feifel, D. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00035 · Cited by 181 · see citing works

Nose-to-brain peptide delivery – The potential of nanotechnology

Samaridou, E., & Alonso, M. J. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.001 · Cited by 178 · see citing works

Intranasal Insulin for Alzheimer’s Disease

Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 182 · see citing works

Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood

Lee, S.-H., Zabolotny, J. M., Huang, H., Lee, H., & Kim, Y.-B. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.011 · Cited by 176 · see citing works

Intranasal Insulin to Improve Memory Function in Humans

Benedict, C., Hallschmid, M., Schultes, B., Jan Born, A., & Kern, W. (2007) · Neuroendocrinology · doi:10.1159/000106378 · Cited by 171 · see citing works

Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions

Schiöth, H. B., Craft, S., Brooks, S. J., Frey, W. H., & Benedict, C. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8229-6 · Cited by 168 · see citing works

Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

de la Monte, S. M., Longato, L., Tong, M., & Wands, J. R. (2009) · PubMed · Cited by 167 · see citing works

Obese men respond to cognitive but not to catabolic brain insulin signaling

Hallschmid, M., Benedict, C., Schultes, B., Born, J., & Kern, W. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803722 · Cited by 165 · see citing works

Effect of Intranasal Insulin on Cognitive Function: A Systematic Review

Shemesh, E., Rudich, A., Harman-Boehm, I., & Cukierman-Yaffe, T. (2012) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2011-1802 · Cited by 162 · see citing works

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

Benedict, C., Frey, W. H., Schiöth, H. B., Schultes, B., Jan Born, A., & Hallschmid, M. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.026 · Cited by 158 · see citing works

GluT4: A central player in hippocampal memory and brain insulin resistance

McNay, E. C., & Pearson-Leary, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113076 · Cited by 156 · see citing works

Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats

Zhang, W.-J., Tan, Y., Yue, J. T. Y., Vranić, M., & Wojtowicz, J. M. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00928.x · Cited by 150 · see citing works

Nose-to-brain delivery of insulin enhanced by a nanogel carrier

Picone, P., Sabatino, M. A., Ditta, L. A., Amato, A., San Biagio, P. L., Mulè, F., Giacomazza, D., Dispenza, C., & Di Carlo, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.040 · Cited by 148 · see citing works

Metabolic Syndrome as a Risk Factor for Alzheimer’s Disease: A Focus on Insulin Resistance

Ezkurdia, A., Ramírez, M. J., & Solas, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054354 · Cited by 153 · see citing works

Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer’s rat model

Guo, Z., Chen, Y., Mao, Y., Zheng, T., Jiang, Y., Yan, Y., Yin, X., & Zhang, B. (2017) · Scientific Reports · doi:10.1038/srep45971 · Cited by 143 · see citing works

Insulin action in the brain regulates both central and peripheral functions

Agrawal, R., Reno, C. M., Sharma, S., CHRISTENSEN, C. G., Huang, Y., & Fisher, S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00642.2020 · Cited by 143 · see citing works

The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota

Leblhuber, F., Ehrlich, D., Steiner, K., Geisler, S., Fuchs, D., Lanser, L., & Kurz, K. (2021) · Nutrients · doi:10.3390/nu13020361 · Cited by 145 · see citing works

Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism

Ott, V., Benedict, C., Schultes, B., Born, J., & Hallschmid, M. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01490.x · Cited by 139 · see citing works

Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: a systematic review

Avgerinos, K. I., Kalaitzidis, G., Malli, A., Kalaitzoglou, D., Myserlis, E. P., & Lioutas, V. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8768-0 · Cited by 137 · see citing works

Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression

Hamer, J., Testani, D. A., Mansur, R. B., Lee, Y. L., Subramaniapillai, M., & McIntyre, R. S. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.01.016 · Cited by 139 · see citing works

Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: Social versus non-social effects

Lukas, M., & Neumann, I. D. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.016 · Cited by 133 · see citing works

Intranasal Mucoadhesive Microemulsion of Tacrine to Improve Brain Targeting

Jogani, V. V., Shah, P., Mishra, P., Mishra, A. K., & Misra, A. R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318157205b · Cited by 127 · see citing works

Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice

Chen, Y., Yang, Z., Dai, C., Liang, Z., Run, X., Iqbal, K., Liu, F., & Gong, C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.004 · Cited by 125 · see citing works

Precision Nanomedicine in Neurodegenerative Diseases

Goldsmith, M., Abramovitz, L., & Peer, D. (2014) · ACS Nano · doi:10.1021/nn501292z · Cited by 124 · see citing works

Thyroid Hormone Signaling and Homeostasis During Aging

Bowers, J., Terrien, J., Clerget-Froidevaux, M. S., Gothié, J. D., Rozing, M. P., Westendorp, R. G. J., van Heemst, D., & Demeneix, B. A. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1056 · Cited by 117 · see citing works

Nose-to-brain drug delivery: from bench to bedside

Drath, I., Richter, F., & Feja, M. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00481-w · Cited by 128 · see citing works

Brain delivery of proteins by the intranasal route of administration: A comparison of cationic liposomes versus aqueous solution formulations

Migliore, M. M., Vyas, T. K., Campbell, R. B., Amiji, M. M., & Waszczak, B. L. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21939 · Cited by 117 · see citing works

Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but Not in Overweight Men

Heni, M., Wagner, R., Kullmann, S., Gancheva, S., Roden, M., Peter, A., Stefan, N., Preissl, H., Häring, H.-U., & Fritsche, A. (2017) · Diabetes · doi:10.2337/db16-1380 · Cited by 115 · see citing works

Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke

Lioutas, V., Alfaro-Martinez, F., Bedoya, F. J., Chung, C., Maldonado, D. P., & Novak, V. (2015) · Translational Stroke Research · doi:10.1007/s12975-015-0409-7 · Cited by 114 · see citing works

O‐GlcNAcylation: A regulator of tau pathology and neurodegeneration

Gong, C., Liu, F., & Iqbal, K. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.02.011 · Cited by 111 · see citing works

Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides

Kamei, N., & Takeda‐Morishita, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.004 · Cited by 111 · see citing works

Safety of intranasal human insulin: A review

Schmid, V., Kullmann, S., Gfrörer, W., Hund, V., Hallschmid, M., Lipp, H., Häring, H., Preissl, H., Fritsche, A., & Heni, M. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13279 · Cited by 110 · see citing works

Intranasal insulin

Hallschmid, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12934 · Cited by 113 · see citing works

A randomized, double‐blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder

McIntyre, R. S., Soczynska, J. K., Woldeyohannes, H. O., Miranda, A., Vaccarino, A., MacQueen, G., Lewis, G. F., & Kennedy, S. H. (2012) · Bipolar Disorders · doi:10.1111/bdi.12006 · Cited by 104 · see citing works

Intranasal insulin in Alzheimer's disease: Food for thought

Chapman, C. D., Schiöth, H. B., Grillo, C. A., & Benedict, C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.037 · Cited by 101 · see citing works

Depression and Cognitive Impairment—Extrahepatic Manifestations of NAFLD and NASH

Colognesi, M., Gabbia, D., & De Martin, S. (2020) · Biomedicines · doi:10.3390/biomedicines8070229 · Cited by 98 · see citing works

Focused ultrasound combined with microbubble-mediated intranasal delivery of gold nanoclusters to the brain

Ye, D., Zhang, X., Yue, Y., Raliya, R., Biswas, P., Taylor, S. J., Tai, Y., Rubin, J. B., Liu, Y., & Chen, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.020 · Cited by 98 · see citing works

Insulin and the brain

Laron, Z. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902949012 · Cited by 97 · see citing works

Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats

Rajasekar, N., Nath, C., Hanif, K., & Shukla, R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0169-8 · Cited by 94 · see citing works

Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review

Benedict, C., & Grillo, C. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00215 · Cited by 96 · see citing works

Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links

Rojas, M., Chávez-Castillo, M., Bautista, J., Ortega, Á., Nava, M., Salazar, J. J., Díaz-Camargo, E. A., Medina, O., Rojas, J., & Bermúdez, V. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.745 · Cited by 96 · see citing works

Insulin Promotes Neuronal Survival via the Alternatively Spliced Protein Kinase CδII Isoform

Apostolatos, A. H., Song, S., Acosta, S., Peart, M. S., Watson, J. E., Bickford, P. C., Cooper, D. R., & Patel, N. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.313080 · Cited by 94 · see citing works

Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

Schmidt, H., Kern, W., Giese, R. M., Hallschmid, M., & Enders, A. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062141 · Cited by 94 · see citing works

Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?

Hallschmid, M., & Schultes, B. (2009) · Diabetologia · doi:10.1007/s00125-009-1501-x · Cited by 90 · see citing works

Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease

Barone, E., Tramutola, A., Triani, F., Calcagnini, S., Di Domenico, F., Ripoli, C., Gaetani, S., Grassi, C., Butterfield, D. A., Cassano, T., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1231-5 · Cited by 86 · see citing works

Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging

Maimaiti, S., Anderson, K. L., DeMoll, C., Brewer, L. D., Rauh, B. A., Gant, J. C., Blalock, E. M., Porter, N. M., & Thibault, O. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu314 · Cited by 87 · see citing works

Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art

de la Monte, S. M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.856877 · Cited by 87 · see citing works

Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences

Sergi, D., Renaud, J., Simola, N., & Martinoli, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00302 · Cited by 85 · see citing works

First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease

Hölscher, C. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.006 · Cited by 83 · see citing works

Deregulation of brain insulin signaling in Alzheimer’s disease

Chen, Y., Deng, Y., Zhang, B., & Gong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1408-x · Cited by 83 · see citing works

Effects of Intranasal Insulin on Hepatic Fat Accumulation and Energy Metabolism in Humans

Gancheva, S., Koliaki, C., Bierwagen, A., Nowotny, P., Heni, M., Fritsche, A., Häring, H.-U., Szendroedi, J., & Roden, M. (2015) · Diabetes · doi:10.2337/db14-0892 · Cited by 81 · see citing works

GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes

Gault, V. A., & Hölscher, C. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.017 · Cited by 80 · see citing works

Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial

Zwanenburg, R. J., Bocca, G., Ruiter, S., Dillingh, J. H., Flapper, B. C. T., van den Heuvel, E. R., & van Ravenswaaij‐Arts, C. M. A. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.109 · Cited by 78 · see citing works

Transnasal Delivery of Methotrexate to Brain Tumors in Rats: A New Strategy for Brain Tumor Chemotherapy

Shingaki, T., Inoue, D., Furubayashi, T., Sakane, T., Katsumi, H., Yamamoto, A., & Yamashita, S. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900275s · Cited by 78 · see citing works

Zinc and the aging brain

Nuttall, J. R., & Oteiza, P. I. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0379-x · Cited by 74 · see citing works

Intranasal Insulin Prevents Anesthesia-Induced Spatial Learning and Memory Deficit in Mice

Zhang, Y., Dai, C., Chen, Y., Iqbal, K., Liu, F., & Gong, C. (2016) · Scientific Reports · doi:10.1038/srep21186 · Cited by 74 · see citing works

Potential role of insulin on the pathogenesis of depression

Zou, X.-H., Sun, L.-H., Yang, W., Li, B.-J., & Cui, R.-J. (2020) · Cell Proliferation · doi:10.1111/cpr.12806 · Cited by 66 · see citing works

Role of Insulin in Neurotrauma and Neurodegeneration: A Review

Shaughness, M., Acs, D., Brabazon, F., Hockenbury, N., & Byrnes, K. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.547175 · Cited by 74 · see citing works

Insulin: An Emerging Treatment for Alzheimer’s Disease Dementia?

Morris, J. K., & Burns, J. M. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0297-0 · Cited by 72 · see citing works

Relationships Between Diabetes and Cognitive Impairment

de la Monte, S. M. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.006 · Cited by 71 · see citing works

Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice

Bomba, M., Granzotto, A., Castelli, V., Massetti, N., Silvestri, E., Canzoniero, L. M. T., Cimini, A., & Sensi, S. L. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.009 · Cited by 69 · see citing works

Central Insulin Administration Improves Odor-Cued Reactivation of Spatial Memory in Young Men

Brünner, Y. F., Kofoet, A., Benedict, C., & Freiherr, J. (2015) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2014-3018 · Cited by 68 · see citing works

Peptides as Potential Therapeutics for Alzheimer’s Disease

Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69 · see citing works

Insulin and ghrelin: peripheral hormones modulating memory and hippocampal function

McNay, E. C. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.009 · Cited by 67 · see citing works

Intranasal insulin improves cerebral blood flow, Nrf‐2 expression and BDNF in STZ (ICV)‐induced memory impaired rats☆

Rajasekar, N., Nath, C., Hanif, K., & Shukla, R. (2017) · Life Science · doi:10.1016/j.lfs.2016.09.020 · Cited by 65 · see citing works

Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases

Yeo, X. Y., Cunliffe, G., Ho, R., Lee, S. S., & Jung, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020343 · Cited by 65 · see citing works

Obesity and episodic memory function

Loprinzi, P. D., & Frith, E. (2018) · The Journal of Physiological Sciences · doi:10.1007/s12576-018-0612-x · Cited by 63 · see citing works

Central Regulation of Glucose Homeostasis

Tups, A., Benzler, J., Sergi, D., Ladyman, S. R., & Williams, L. M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160015 · Cited by 69 · see citing works

Linking insulin with Alzheimer’s disease: emergence as type III diabetes

Ahmed, S. A. A., Mahmood, Z., & Zahid, S. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2352-5 · Cited by 61 · see citing works

Insulin mediated novel therapies for the treatment of Alzheimer's disease

Dubey, S. K., Lakshmi, K. K., Krishna, K. V., Agrawal, M., Singhvi, G., Saha, R. N., Saraf, S., Saraf, S., Shukla, R., & Alexander, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117540 · Cited by 60 · see citing works

The Insulin-Mediated Modulation of Visually Evoked Magnetic Fields Is Reduced in Obese Subjects

Guthoff, M., Stingl, K. T., Tschritter, O., Vidaković, M. R., Heni, M., Štingl, K., Hallschmid, M., Häring, H., Fritsche, A., Preissl, H. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019482 · Cited by 59 · see citing works

Intranasal insulin improves memory in humans

Benedict, C., Hallschmid, M., Hatke, A., Schultes, B., Fehm, H. L., Born, J., & Kern, W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.04.003 · Cited by 699 · see citing works

Intranasal Insulin to Improve Memory Function in Humans

Benedict, C., Hallschmid, M., Schultes, B., Jan Born, A., & Kern, W. (2007) · Neuroendocrinology · doi:10.1159/000106378 · Cited by 171 · see citing works

Improving effect of intranasal administration of insulin on memory in man

Benedict, C., Hallschmid, M., Fehm, H., Schultes, B., Jan Born, A., & Kern, W. (2004) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2004-819302

Intranasal Insulin for Alzheimer’s Disease

Hallschmid, M. (2021) · CNS Drugs · doi:10.1007/s40263-020-00781-x · Cited by 182 · see citing works

Inhaling Insulin May Improve Memory of Alzheimer's Patients

Arehart-Treichel, J. (2004) · Psychiatric News · doi:10.1176/pn.39.23.00390023